<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>didanosine</title><link>http://www.unboundmedicine.com/medline/ebm/research/didanosine</link><description>Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.</description><language>en-us</language><copyright>Unbound Medicine, Inc.</copyright><item><title>Risk of Extended Viral Resistance in Human Immunodeficiency Virus-1-Infected Mozambican Children After First-Line Treatment Failure.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19907359/full_citation/Risk_of_Extended_Viral_Resistance_in_Human_Immunodeficiency_Virus_1_Infected_Mozambican_Children_After_First_Line_Treatment_Failure_</link><description>Vaz P, Chaix ML, Jani I, et al. <br/><span class="title">Risk of Extended Viral Resistance in Human Immunodeficiency Virus-1-Infected Mozambican Children After First-Line Treatment Failure. [JOURNAL ARTICLE]</span><br/><span class="source" title="The Pediatric infectious disease journal">Pediatr Infect Dis J 2009 Nov 10.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19907359/abstract/Risk_of_Extended_Viral_Resistance_in_Human_Immunodeficiency_Virus_1_Infected_Mozambican_Children_After_First_Line_Treatment_Failure_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19907359/full_citation/Risk_of_Extended_Viral_Resistance_in_Human_Immunodeficiency_Virus_1_Infected_Mozambican_Children_After_First_Line_Treatment_Failure_">Full Citation</a></description></item><item><title>Didanosine withdrawal is associated with improved liver function tests.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19906627/full_citation/Didanosine_withdrawal_is_associated_with_improved_liver_function_tests_</link><description>Lafeuillade A, Hittinger G, Cheret A, et al. <br/><span class="title">Didanosine withdrawal is associated with improved liver function tests. [Journal Article]</span><br/><span class="source" title="HIV clinical trials">HIV Clin Trials 2009 Sep-Oct; 10(5):341.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19906627/full_citation/Didanosine_withdrawal_is_associated_with_improved_liver_function_tests_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19906627/Didanosine_withdrawal_is_associated_with_improved_liver_function_tests_">Find Related Articles</a> </description></item><item><title>The cost effectiveness of home-based provision of antiretroviral therapy in rural Uganda.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19905037/full_citation/The_cost_effectiveness_of_home_based_provision_of_antiretroviral_therapy_in_rural_Uganda_</link><description>Marseille E, Kahn JG, Pitter C, et al. <br/><span class="title">The cost effectiveness of home-based provision of antiretroviral therapy in rural Uganda. [Journal Article]</span><br/><span class="source" title="Applied health economics and health policy">Appl Health Econ Health Policy 2009; 7(4):229-43.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19905037/abstract/The_cost_effectiveness_of_home_based_provision_of_antiretroviral_therapy_in_rural_Uganda_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19905037/full_citation/The_cost_effectiveness_of_home_based_provision_of_antiretroviral_therapy_in_rural_Uganda_">Full Citation</a></description></item><item><title>[Treatment of chronic hepatitis C in HIV-infected patients]</title><link>http://www.unboundmedicine.com/medline/ebm/record/19375043/full_citation/[Treatment_of_chronic_hepatitis_C_in_HIV_infected_patients]</link><description>Bani-Sadr F <br/><span class="title">[Treatment of chronic hepatitis C in HIV-infected patients] [English Abstract, Journal Article]</span><br/><span class="source" title="Gastroentérologie clinique et biologique">Gastroenterol Clin Biol 2009 Mar.:S97-S103.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19375043/abstract/[Treatment_of_chronic_hepatitis_C_in_HIV_infected_patients]">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19375043/full_citation/[Treatment_of_chronic_hepatitis_C_in_HIV_infected_patients]">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19375043/[Treatment_of_chronic_hepatitis_C_in_HIV_infected_patients]">Find Related Articles</a> </description></item><item><title>[ANRS HC 02 RIBAVIC: histo-pathological impact]</title><link>http://www.unboundmedicine.com/medline/ebm/record/19375037/full_citation/[ANRS_HC_02_RIBAVIC:_histo_pathological_impact]</link><description>Pol S <br/><span class="title">[ANRS HC 02 RIBAVIC: histo-pathological impact] [English Abstract, Journal Article]</span><br/><span class="source" title="Gastroentérologie clinique et biologique">Gastroenterol Clin Biol 2009 Mar.:S106-9.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19375037/abstract/[ANRS_HC_02_RIBAVIC:_histo_pathological_impact]">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19375037/full_citation/[ANRS_HC_02_RIBAVIC:_histo_pathological_impact]">Full Citation</a></description></item><item><title>Development of a didanosine genotypic resistance interpretation system based on large derivation and validation datasets.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19864933/full_citation/Development_of_a_didanosine_genotypic_resistance_interpretation_system_based_on_large_derivation_and_validation_datasets_</link><description>Assoumou L, Cozzi-Lepri A, Brun-Vézinet F, et al. <br/><span class="title">Development of a didanosine genotypic resistance interpretation system based on large derivation and validation datasets. [JOURNAL ARTICLE]</span><br/><span class="source" title="AIDS (London, England)">AIDS 2009 Oct 27.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19864933/abstract/Development_of_a_didanosine_genotypic_resistance_interpretation_system_based_on_large_derivation_and_validation_datasets_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19864933/full_citation/Development_of_a_didanosine_genotypic_resistance_interpretation_system_based_on_large_derivation_and_validation_datasets_">Full Citation</a> | <a href="http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm%3fissn=0269-9370%26amp;volume=%26amp;issue=%26amp;spage=">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19864933/Development_of_a_didanosine_genotypic_resistance_interpretation_system_based_on_large_derivation_and_validation_datasets_">Find Related Articles</a> </description></item><item><title>Five-year follow up of genotypic resistance patterns in HIV-1 subtype C infected patients in Botswana after failure of thymidine analogue-based regimens.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19852859/full_citation/Five_year_follow_up_of_genotypic_resistance_patterns_in_HIV_1_subtype_C_infected_patients_in_Botswana_after_failure_of_thymidine_analogue_based_regimens_</link><description>Doualla-Bell F, Gaolathe T, Avalos A, et al. <br/><span class="title">Five-year follow up of genotypic resistance patterns in HIV-1 subtype C infected patients in Botswana after failure of thymidine analogue-based regimens. [JOURNAL ARTICLE]</span><br/><span class="source" title="Journal of the International AIDS Society">J Int AIDS Soc 2009 Oct 25; 12(1):25.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19852859/abstract/Five_year_follow_up_of_genotypic_resistance_patterns_in_HIV_1_subtype_C_infected_patients_in_Botswana_after_failure_of_thymidine_analogue_based_regimens_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19852859/full_citation/Five_year_follow_up_of_genotypic_resistance_patterns_in_HIV_1_subtype_C_infected_patients_in_Botswana_after_failure_of_thymidine_analogue_based_regimens_">Full Citation</a></description></item><item><title>High Rates of Survival, Immune Reconstitution and Virologic Suppression on Second-Line Antiretroviral Therapy in South Africa.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19838128/full_citation/High_Rates_of_Survival_Immune_Reconstitution_and_Virologic_Suppression_on_Second_Line_Antiretroviral_Therapy_in_South_Africa_</link><description>Fox MP, Ive P, Long L, et al. <br/><span class="title">High Rates of Survival, Immune Reconstitution and Virologic Suppression on Second-Line Antiretroviral Therapy in South Africa. [JOURNAL ARTICLE]</span><br/><span class="source" title="Journal of acquired immune deficiency syndromes (1999)">J Acquir Immune Defic Syndr 2009 Oct 15.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19838128/abstract/High_Rates_of_Survival_Immune_Reconstitution_and_Virologic_Suppression_on_Second_Line_Antiretroviral_Therapy_in_South_Africa_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19838128/full_citation/High_Rates_of_Survival_Immune_Reconstitution_and_Virologic_Suppression_on_Second_Line_Antiretroviral_Therapy_in_South_Africa_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19838128/High_Rates_of_Survival_Immune_Reconstitution_and_Virologic_Suppression_on_Second_Line_Antiretroviral_Therapy_in_South_Africa_">Find Related Articles</a> </description></item><item><title>Didanosine polymorphism in a supercritical antisolvent process.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19827134/full_citation/Didanosine_polymorphism_in_a_supercritical_antisolvent_process_</link><description>Bettini R, Menabeni R, Tozzi R, et al. <br/><span class="title">Didanosine polymorphism in a supercritical antisolvent process. [JOURNAL ARTICLE]</span><br/><span class="source" title="Journal of pharmaceutical sciences">J Pharm Sci 2009 Oct 13.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19827134/abstract/Didanosine_polymorphism_in_a_supercritical_antisolvent_process_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19827134/full_citation/Didanosine_polymorphism_in_a_supercritical_antisolvent_process_">Full Citation</a></description></item><item><title>Durability of Initial Antiretroviral Therapy in a Resource Constrained Setting and the Potential Need for Zidovudine Weight-Based Dosing.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19797973/full_citation/Durability_of_Initial_Antiretroviral_Therapy_in_a_Resource_Constrained_Setting_and_the_Potential_Need_for_Zidovudine_Weight_Based_Dosing_</link><description>Willig JH, Echevarria J, Westfall AO, et al. <br/><span class="title">Durability of Initial Antiretroviral Therapy in a Resource Constrained Setting and the Potential Need for Zidovudine Weight-Based Dosing. [JOURNAL ARTICLE]</span><br/><span class="source" title="Journal of acquired immune deficiency syndromes (1999)">J Acquir Immune Defic Syndr 2009 Sep 30.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19797973/abstract/Durability_of_Initial_Antiretroviral_Therapy_in_a_Resource_Constrained_Setting_and_the_Potential_Need_for_Zidovudine_Weight_Based_Dosing_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19797973/full_citation/Durability_of_Initial_Antiretroviral_Therapy_in_a_Resource_Constrained_Setting_and_the_Potential_Need_for_Zidovudine_Weight_Based_Dosing_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19797973/Durability_of_Initial_Antiretroviral_Therapy_in_a_Resource_Constrained_Setting_and_the_Potential_Need_for_Zidovudine_Weight_Based_Dosing_">Find Related Articles</a> </description></item></channel></rss>